Company profile for DMK Pharmaceuticals

NEW Drugs in Dev: 2
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

DMK Pharmaceuticals is reimagining neurotherapies for central nervous system disorders of significant unmet need. We have a wholly-owned library of high value, first-in-class compounds and a differentiated pipeline that addresses the need for novel therapies which integrate with the body’s own efforts to regain balance of disrupted brain circuitry. By designing small molecule analogs of neuropeptides, multiple receptors can ...
DMK Pharmaceuticals is reimagining neurotherapies for central nervous system disorders of significant unmet need. We have a wholly-owned library of high value, first-in-class compounds and a differentiated pipeline that addresses the need for novel therapies which integrate with the body’s own efforts to regain balance of disrupted brain circuitry. By designing small molecule analogs of neuropeptides, multiple receptors can be targeted simultaneously and support a gradual transition back to a balanced neurophysiological state.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11 Sheephill Drive Gladstone, NJ 07934
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/zmi-management-inc-finalizes-acquisition-of-zimhi-from-dmk-pharmaceuticals-corporation-partners-with-fff-enterprises-as-sole-distributor-302177871.html

PR NEWSWIRE
20 Jun 2024

https://www.globenewswire.com//news-release/2023/11/28/2786908/32832/en/DMK-Pharmaceuticals-Regains-Full-Rights-from-US-WorldMeds-for-SYMJEPI-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
28 Nov 2023

https://www.globenewswire.com//news-release/2023/11/14/2779964/32832/en/DMK-Pharmaceuticals-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
14 Nov 2023

https://www.globenewswire.com//news-release/2023/11/13/2779211/32832/en/DMK-Pharmaceuticals-Announces-Presentation-of-Preclinical-Results-Comparing-Effects-of-DPI-125-on-Opioid-Withdrawal-Behaviors-Versus-Standard-of-Care-for-Opioid-Use-Disorder-at-SfN.html

GLOBENEWSWIRE
13 Nov 2023

https://www.globenewswire.com//news-release/2023/10/20/2764235/32832/en/DMK-Pharmaceuticals-Announces-Inducement-Option-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
20 Oct 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty